Researchers have found that IL‐11 is significantly overexpressed in various cancer types, including TNBC, and patients with elevated IL‐11 levels often experience poorer prognoses.[45, 58, 59, 60, 61, 62] In TNBC, intra‐tumoral heterogeneity is a notable characteristic. The gene discussed is IL11; the disease is cancer.